Security key
70465T107
- Security type / class
- Equity / Common
- Total 13F shares
- 7,451,352
- Total 13F value
- $9,901,943
- Share change
- -789,100
- Put/Call ratio
- 0%
- SEC-reported price per share
- $1.33
- Number of holders
- 55
- Value change
- -$1,043,791
- Number of buys
- 25
- Number of sells
- 19
- Shares outstanding
- 49,594,356
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2025
Institutions
55
Top holders
10
PDSB full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Previous quarter: Q1 2025
PDS Biotechnology Corp SEC filings
PDS Biotechnology Corp company facts
Broader feeds
Reporting periods
Holder history for CUSIP 70465T107
Recent filing periods:
Ownership snapshot
Top reported holders of PDSB - PDS Biotechnology Corp - Common (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ARMISTICE CAPITAL, LLC
Disclosed value leader
ARMISTICE CAPITAL, LLC
Comparable rows
15/15
Latest evidence
31 Mar 2025
13F
Lead comparable stake: 8.9%
Showing 1-6 of 15 holder rows.
Quick read
ARMISTICE CAPITAL, LLC leads the comparable SEC ownership view at 8.9%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ARMISTICE CAPITAL, LLC's linked filing trail.
Comparable ownership
Top 5
ARMISTICE CAPITAL, LLC
8.9%
VANGUARD GROUP INC
3%
BlackRock, Inc.
0.98%
GEODE CAPITAL MANAGEMENT, LLC
0.88%
BLAIR WILLIAM & CO/IL
0.52%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13F
Company
|
8.9%
|
$5,258,610
4,419,000 shares
|
— | 31 Mar 2025 |
| VANGUARD GROUP INC |
13F
Company
|
3%
|
$1,797,163
1,510,221 shares
|
— | 31 Mar 2025 |
| BlackRock, Inc. |
13F
Company
|
0.98%
|
$580,759
488,033 shares
|
— | 31 Mar 2025 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.88%
|
$521,194
437,881 shares
|
— | 31 Mar 2025 |
| BLAIR WILLIAM & CO/IL |
13F
Company
|
0.52%
|
$306,068
257,200 shares
|
— | 31 Mar 2025 |
| UBS Group AG |
13F
Company
|
0.51%
|
$298,876
251,156 shares
|
— | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
55
Shares
7,451,352
Rows available
55
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
46
Q2 2025 holders
55
Holder diff
9
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q2 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend